Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Call Options Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $143 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$103 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$60.2 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$43 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$37.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$30.4 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $583M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...